Page results
-
This page describes a surgical keyhole procedure to remove fibroids, called a laparoscopic myomectomy.
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
EMIS outage caused backlog of result messages via Keystone
-
This page provides information about the Palliative care and symptom control team
-
Contact details of clinical lead adults and lead paediatrics
-
This patient information explains an inguinal gonadectomy.
-
This patient information explains laparoscopic gonadectomy.
-
Information about hyperthermic intraperitoneal chemotherapy (HIPEC), including about the risks and benefits, and alternatives to the treatment.
File results
-
FOI/2021/0696 - Procurement of Robotic Process Automation (RPA)
-
FOI/2021/0708 - Treatment of dermatological conditions
-
FOI/2021/0738 - Ruptured ectopic pregnancies
-
FOI/2021/0746 - Overseas visitors
-
FOI/2021/0745 - Referrals to psychosexual services
-
FOI/2021/0749 - Private contractors
-
FOI/2022/0023 - Assault attendances to ED
-
FOI/2022/0024 - Protocols for major haemorrhaging in hospital
-
FOI/2022/0026 - Patients referred for puberty blockers/ services related to gender identity
-
FOI/2022/0029 - Treatment and charges for overseas visitors and migrants